Low-level transcutaneous electrical stimulation of the auricular branch of vagus nerve ameliorates left ventricular remodeling and dysfunction by downregulation of matrix metalloproteinase 9 and transforming growth factor β1

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 4, 2015, Pages 342-348

  Wang, Zhuo ^a   Yu, Lilei ^a   Huang, Bing ^a   Wang, Songyun ^a   Liao, Kai ^a   Saren, Gaowa ^a   Zhou, Xiaoya ^a   Jiang, Hong ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Left ventricular remodeling; Matrix metalloproteinase 9; Myocardial infarction; Transforming growth factor 1; Vagus nerve stimulation

Indexed keywords

GELATINASE B; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; DISEASE MODEL; DOG; DOWN REGULATION; ETIOLOGY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE; HEART VENTRICLE REMODELING; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DOWN-REGULATION; HEART VENTRICLES; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; STROKE VOLUME; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84929331801     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000201     Document Type: Article

References (38)

1. McKelvie RS, Benedict CR, Yusuf S. Evidence based cardiology: prevention of congestive heart failure and management of asymptomatic left ventricular dysfunction. BMJ. 1999;318:1400-1402.
2. Liao K, Yu L, He B, et al. Carotid baroreceptor stimulation prevents arrhythmias induced by acute myocardial infarction through autonomic modulation. J Cardiovasc Pharmacol. 2014;64:431-437.
3. Yu L, Huang B, He W, et al. Spinal cord stimulation suppresses focal rapid firing induced atrial fibrillation by inhibiting atrial ganglionated plexus activity. J Cardiovasc Pharmacol. 2014;64:554-559.
4. Wang Z, Yu L, Chen M, et al. Transcutaneous electrical stimulation of auricular branch of vagus nerve: a non-invasive therapeutic approach for post-ischemic heart failure. Int J Cardiol. 2014;177:676-677.
5. Yokota T, Tomita H, Mori Y, et al. Imidapril and enalapril similarly inhibit plasma matrix metalloproteinase activities and attenuate left ventricular remodeling in patients with acute myocardial infarction. J Cardiovasc Pharmacol. 2014;63:528-532.
6. Lu Y, Liu JJ, Bi XY, et al. Pyridostigmine ameliorates cardiac remodeling induced by myocardial infarction via inhibition of the transforming growth factor-beta1/TGF-beta1-activated kinase pathway. J Cardiovasc Pharmacol. 2014;63:412-420.
7. See F, Thomas W, Way K, et al. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. J Am Coll Cardiol. 2004;44:1679-1689.
8. Lu L, Feng M, Gu J, et al. Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-beta is critical for immune homeostasis following acute liver injury. J Mol Cell Biol. 2013;5:369-379.
9. Huang B, Yu L, He B, et al. Renal sympathetic denervation Modulates ventricular electrophysiology and has a protective effect on ischemia-induced ventricular arrhythmia. Exp Physiol. 2014;99:1467-1477.
10. Yu L, Scherlag BJ, Dormer K, et al. Autonomic denervation with magnetic nanoparticles. Circulation. 2010;122:2653-2659.
11. Yu L, Scherlag BJ, Sha Y, et al. Interactions between atrial electrical remodeling and autonomic remodeling: how to break the vicious cycle. Heart Rhythm. 2012;9:804-809.
12. Huang B, Yu L, Scherlag BJ, et al. Left renal nerves stimulation facilitates ischemia-induced ventricular arrhythmia by increasing nerve activity of left stellate ganglion. J Cardiovasc Electrophysiol. 2014;25:1249-1256.
13. Yu L, Scherlag BJ, Li S, et al. Low-level vagosympathetic nerve stimulation inhibits atrial fibrillation inducibility: direct evidence by neural recordings from intrinsic cardiac ganglia. J Cardiovasc Electrophysiol. 2011;22:455-463.
14. Uemura K, Li M, Tsutsumi T, et al. Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit. Am J Physiol Heart Circ Physiol. 2007;293:H2254-H2261.
15. Zhang Y, Popovic ZB, Bibevski S, et al. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail. 2009;2:692-699.
16. Yu L, Scherlag BJ, Li S, et al. Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation. Heart Rhythm. 2013;10:428-435.
17. Wang Z, Yu L, Wang S, et al. Chronic intermittent low-level transcutaneous electrical stimulation of auricular branch of vagus nerve improves left ventricular remodeling in conscious dogs with healed myocardial infarction. Circ Heart Fail. 2014;7:1014-1021.
18. He W, Wang X, Shi H, et al. Auricular acupuncture and vagal regulation. Evid Based Complement Alternat Med. 2012;2012:786839.
19. Nomura S, Mizuno N. Central distribution of efferent and afferent components of the cervical branches of the vagus nerve. A HRP study in the cat. Anat Embryol (Berl). 1983;166:1-18.
20. Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev. 2005;29:493-500.
21. Gao XY, Zhang SP, Zhu B, et al. Investigation of specificity of auricular acupuncture points in regulation of autonomic function in anesthetized rats. Auton Neurosci. 2008;138:50-56.
22. Ogawa M, Zhou S, Tan AY, et al. Left stellate ganglion and vagal nerve activity and cardiac arrhythmias in ambulatory dogs with pacing-induced congestive heart failure. J Am Coll Cardiol. 2007;50:335-343.
23. Shinlapawittayatorn K, Chinda K, Palee S, et al. Low-amplitude, left vagus nerve stimulation significantly attenuates ventricular dysfunction and infarct size through prevention of mitochondrial dysfunction during acute ischemia-reperfusion injury. Heart Rhythm. 2013;10:1700-1707.
24. Li S, Scherlag BJ, Yu L, et al. Low-level vagosympathetic stimulation: a paradox and potential new modality for the treatment of focal atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2:645-651.
25. Sheng X, Scherlag BJ, Yu L, et al. Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level vagosympathetic nerve stimulation. J Am Coll Cardiol. 2011;57:563-571.
26. Sha Y, Scherlag BJ, Yu L, et al. Low-level right vagal stimulation: anticholinergic and antiadrenergic effects. J Cardiovasc Electrophysiol. 2011;22:1147-1153.
27. Stavrakis S, Scherlag BJ, Fan Y, et al. Antiarrhythmic effects of vasostatin-1 in a canine model of atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23:771-777.
28. Stavrakis S, Scherlag BJ, Fan Y, et al. Inhibition of atrial fibrillation by low-level vagus nerve stimulation: the role of the nitric oxide signaling pathway. J Interv Card Electrophysiol. 2013;36:199-208.
29. Tseliou E, de Couto G, Terrovitis J, et al. Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation postinfarction by intramyocardially-injected cardiospheres. PLoS One. 2014;9:e88590.
30. Jugdutt BI. Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation. 2003;108:1395-1403.
31. Dicarlo L, Libbus I, Amurthur B, et al. Autonomic regulation therapy for the improvement of left ventricular function and heart failure symptoms: the ANTHEM-HF study. J Cardiac Fail. 2013;19:655-660.
32. Malliani A, Pagani M. The role of the sympathetic nervous system in congestive heart failure. Eur Heart J. 1983;4(suppl A):49-54.
33. Kaye DM, Lefkovits J, Jennings GL, et al. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
34. Swedberg K, Eneroth P, Kjekshus J, et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990;82:1730-1736.
35. He W, Jing X, Wang X, et al. Transcutaneous auricular vagus nerve stimulation as a complementary therapy for pediatric epilepsy: a pilot trial. Epilepsy Behav. 2013;28:343-346.
36. Greif R, Laciny S, Mokhtarani M, et al. Transcutaneous electrical stimulation of an auricular acupuncture point decreases anesthetic requirement. Anesthesiology. 2002;96:306-312.
37. Huston JM, Gallowitsch-Puerta M, Ochani M, et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med. 2007;35:2762-2768.
38. Shen MJ, Shinohara T, Park HW, et al. Continuous low-level vagus nerve stimulation reduces stellate ganglion nerve activity and paroxysmal atrial tachyarrhythmias in ambulatory canines. Circulation. 2011;123: 2204-2212.